Monday, May 13, 2024
Home 2020

Yearly Archives: 2020

Superbug News - CoronaVirus Watch List

Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys...

Editor / Curator -
video
Superbug News - CoronaVirus Watch List

CoronaVirus Story of the Day. “How Lucky Can One Guy Be.”

Editor / Curator -
Superbug News - CoronaVirus Watch List

Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.

Editor / Curator -
Aphex BioCleanse
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.

Editor / Curator -
Stand Down.

Stand Down VII: Could We Have a Down 20% Day?

Editor / Curator -
Superbug News - CoronaVirus Watch List

Telehealth DTC Startup Ro is now Offering Coronavirus Assessments (ModernRetail).

Editor / Curator -
coronavirus stocks
Superbug News - CoronaVirus Watch List

Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Coronavirus Stocks Still on a Tear.

Editor / Curator -
Draganfly
AI Artificial Intelligence

Draganfly (DFLYF) Closes $15 Million Reg A Offering.

Editor / Curator -
video
Video

What is Bacteria? Structure & Types, Prof. Dr. Vincent Racaniello (Lecturio).

Editor / Curator -
1...161718...20Page 17 of 20

Latest article

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

2024 Watch List Editor / Curator -
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

2024 Watch List Editor / Curator -
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...

COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Biotech News Editor / Curator -
Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.